IBRX
$9.18-8.20%
as of close, Oct 16, 2026
☾ AH $9.18 -8.20%
ImmunityBio Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.02%Russell 3000 0.005%US Stock Market 0.004%
ImmunityBio Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
ImmunityBio Inc. total returns by year (2016–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $1.98 | $9.18 | 0.0% | +363.6% | |
| 2025 | $2.56 | $1.98 | 0.0% | -22.7% | |
| 2024 | $5.02 | $2.56 | 0.0% | -49.0% | |
| 2023 | $5.07 | $5.02 | 0.0% | -1.0% | |
| 2022 | $6.08 | $5.07 | 0.0% | -16.6% | |
| 2021 | $13.33 | $6.08 | 0.0% | -54.4% | |
| 2020 | $3.79 | $13.33 | 0.0% | +251.7% | |
| 2019 | $1.16 | $3.79 | 0.0% | +226.7% | |
| 2018 | $4.49 | $1.16 | 0.0% | -74.2% | |
| 2017 | $5.72 | $4.49 | 0.0% | -21.5% | |
| 2016 | $17.33 | $5.72 | 0.0% | -67.0% |
- Annualized
- -10.2%
- 2016–2026
- Average year
- +17.2%
- 10 full years
- Best year
- +251.7%
- 2020
- Worst year
- -74.2%
- 2018
- Positive years
- 2/10
- 20% up
Annualized (CAGR)
-10.2%
2016–2026
Average year
+17.2%
10 full years
Best year
+251.7%
2020
Worst year
-74.2%
2018
Positive years
2/10
20% up
Total return by period#
Annual
-300%-200%-100%0%100%200%300%
2016-67%'16
2017-22%'17
2018-74%'18
2019+227%'19
2020+252%'20
2021-54%'21
2022-17%'22
2023-0.99%'23
2024-49%'24
2025-23%'25
2026+364%'26
Methodology#
Total returns, dividends reinvested, measured on IBRX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is ImmunityBio Inc.'s average annual return?
- Since 2016, ImmunityBio Inc. (IBRX) has returned about -10.2% a year (the compound annual growth rate) and an average calendar-year return of 17.2%.
- What were ImmunityBio Inc.'s best and worst years?
- Over 2016–2026, the best year was 2020 (+251.7%) and the worst was 2018 (-74.2%).
- How often is ImmunityBio Inc. up in a year?
- 2 of the 10 full years since 2016 were positive — about 20% of the time.
More on ImmunityBio Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100